Its function in prostate cancer lies in the overexpression of E26 transformation-specific (ETS) transcription factors, such as ETS-related gene (ERG) and ETS translocation variant 1 (ETV1) through gene fusion [29]. This evidence concerns the gene ERG and prostate carcinoma.